Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-052334

Director bought 55,000 shares at $18.00 ($990,000)

  • Director acquired 6,414,356 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

ORONSKY ARNOLD L · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-25 Purchase : show line 1 in the form +55,000 $18.00 $990,000 55,000 I
2020-09-29 Conversion : show line 2 in the form +1,620,101 1,675,101 I
2020-09-29 Conversion : show line 3 in the form +3,488,398 5,163,499 I
2020-09-29 Conversion : show line 4 in the form +1,040,654 6,204,153 I
2020-09-29 Conversion : show line 5 in the form +265,203 6,469,356 I
Open-market purchases · 55,000 sh · avg $18.00 · $990,000

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2020-09-29 Conversion : show line 6 in the form Series Seed Preferred Stock −1,620,101 0 I
2020-09-29 Conversion : show line 7 in the form Series A Preferred Stock −3,488,398 0 I
2020-09-29 Conversion : show line 8 in the form Series B Preferred Stock −1,040,654 0 I
2020-09-29 Conversion : show line 9 in the form Series C Preferred Stock −265,203 0 I
Loading xslF345X03/doc4.xml…